{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiceot3fhau5air3b3dxlue7nyi6j2oj7hvffnfhiwupgyvpw3em5i",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mg3sezvy6f22"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreic5udpt2q5sqluo64tfde7gwfo46jrqlllrgshc7ol7lh74gmoqqy"
    },
    "mimeType": "image/jpeg",
    "size": 111846
  },
  "path": "/2026/03/02/biotech-news-merck-renal-cell-carcinoma-drug/?utm_campaign=rss",
  "publishedAt": "2026-03-02T14:41:10.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Business",
    "Pharma",
    "The Readout",
    "biotechnology",
    "drug development",
    "Drug prices",
    "research"
  ],
  "textContent": "UniQure seeks approval, Novartis settles Henrietta Lacks lawsuit, and more biotech stories",
  "title": "STAT+: A Merck cancer drug to watch",
  "updatedAt": "2026-03-02T14:41:14.000Z"
}